# Alaunos Therapeutics, Inc.: Form 8-K, filed Jun 26, 2025

- Company: [Alaunos Therapeutics, Inc.](/companies/tcrt.md) (CIK 1107421)
- Form: 8-K
- Filed: 2025-06-26
- Accepted by EDGAR: Jun 26, 2025, 12:45 ET
- Period: 2025-06-24
- Accession: 0000950170-25-090201
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1107421/000095017025090201/tcrt-20250624.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1107421/000095017025090201/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 3.02: Unregistered sale of equity
- Item 3.03: Change to security holders’ rights
- Item 5.03: Amendment to articles or bylaws
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1107421/000095017025090201/tcrt-20250624.htm

Filed Jun 26, 2025.
Source: SEC EDGAR, the filing index for accession 0000950170-25-090201. Last ingested by Listed: Oct 24, 2026, 15:04 ET. No prices; not investment advice.